Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Curt D Furberg

Showing results (131-140 of 169) with videos related to

Pageof 17
Sort By:
European Journal of Preventive Cardiology|January 31, 2015
Apolipoprotein B improves risk assessment of future coronary heart disease in the Framingham Heart Study beyond LDL-C and non-HDL-CMichael J Pencina, Ralph B D'Agostino, Tomasz Zdrojewski, et al.
American Heart Journal|January 24, 2007
Alcohol consumption and risk and prognosis of atrial fibrillation among older adults: the Cardiovascular Health StudyKenneth J Mukamal, Bruce M Psaty, Pentti M Rautaharju, et al.
Stroke|December 1, 2004
Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health StudyW T Longstreth, Alice M Arnold, Norman J Beauchamp, et al.
American Journal of Hematology|April 3, 2008
Lipoprotein-associated phospholipase A2 and risk of venous thrombosis in older adultsNels Olson, Ellen S O'Meara, Nancy S Jenny, et al.
Journal of General Internal Medicine|January 30, 2008
Cost-effectiveness of chlorthalidone, amlodipine, and lisinopril as first-step treatment for patients with hypertension: an analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Paul A Heidenreich, Barry R Davis, Jeffrey A Cutler, et al.
American Heart Journal|September 20, 2005
Association of beta-blocker use with mortality among patients with congestive heart failure in the Cardiovascular Health Study (CHS)Jeannie D Chan, Thomas D Rea, Nicholas L Smith, et al.
Circulation. Cardiovascular Quality and Outcomes|February 4, 2010
Does Ginkgo biloba reduce the risk of cardiovascular events?Lewis H Kuller, Diane G Ives, Annette L Fitzpatrick, et al.
Journal of the American Geriatrics Society|September 29, 2004
Risk of congestive heart failure in an elderly population treated with peripheral alpha-1 antagonistsChris L Bryson, Nicholas L Smith, Lewis H Kuller, et al.
Journal of Clinical Epidemiology|April 8, 2009
A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designersKevin E Thorpe, Merrick Zwarenstein, Andrew D Oxman, et al.
Circulation|October 7, 2008
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus DocumentsDeepak L Bhatt, James Scheiman, Neena S Abraham, et al.
Pageof 17

Showing results (131-140 of 169) with videos related to

Sort By:
Pageof 17
European Journal of Preventive Cardiology|January 31, 2015
Apolipoprotein B improves risk assessment of future coronary heart disease in the Framingham Heart Study beyond LDL-C and non-HDL-CMichael J Pencina, Ralph B D'Agostino, Tomasz Zdrojewski, et al.
American Heart Journal|January 24, 2007
Alcohol consumption and risk and prognosis of atrial fibrillation among older adults: the Cardiovascular Health StudyKenneth J Mukamal, Bruce M Psaty, Pentti M Rautaharju, et al.
Stroke|December 1, 2004
Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health StudyW T Longstreth, Alice M Arnold, Norman J Beauchamp, et al.
American Journal of Hematology|April 3, 2008
Lipoprotein-associated phospholipase A2 and risk of venous thrombosis in older adultsNels Olson, Ellen S O'Meara, Nancy S Jenny, et al.
Journal of General Internal Medicine|January 30, 2008
Cost-effectiveness of chlorthalidone, amlodipine, and lisinopril as first-step treatment for patients with hypertension: an analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Paul A Heidenreich, Barry R Davis, Jeffrey A Cutler, et al.
American Heart Journal|September 20, 2005
Association of beta-blocker use with mortality among patients with congestive heart failure in the Cardiovascular Health Study (CHS)Jeannie D Chan, Thomas D Rea, Nicholas L Smith, et al.
Circulation. Cardiovascular Quality and Outcomes|February 4, 2010
Does Ginkgo biloba reduce the risk of cardiovascular events?Lewis H Kuller, Diane G Ives, Annette L Fitzpatrick, et al.
Journal of the American Geriatrics Society|September 29, 2004
Risk of congestive heart failure in an elderly population treated with peripheral alpha-1 antagonistsChris L Bryson, Nicholas L Smith, Lewis H Kuller, et al.
Journal of Clinical Epidemiology|April 8, 2009
A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designersKevin E Thorpe, Merrick Zwarenstein, Andrew D Oxman, et al.
Circulation|October 7, 2008
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus DocumentsDeepak L Bhatt, James Scheiman, Neena S Abraham, et al.
Pageof 17